| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $963K | +12.3% |
| SG&A Expense | $31.7M | -15.6% |
| Operating Income | -$33.7M | +10.6% |
| Net Income | -$33.5M | +19.7% |
| EPS (Basic) | -$0.05 | +37.5% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.0M | +125.7% |
| Current Assets | $29.9M | +111.4% |
| Total Assets | $52.9M | +148.6% |
| Current Liabilities | $3.1M | +67.5% |
| Total Liabilities | $3.2M | +77.1% |
| Stockholders' Equity | $49.6M | +155.3% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.2M | -31.2% |
| Capital Expenditures | $12.9M | +136.7% |
| Investing Cash Flow | -$15.1M | -112.9% |
| Financing Cash Flow | $41.4M | +54.2% |
| Free Cash Flow | -$23.1M | -74.7% |